Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 27 (5) , 492-499
Abstract
No abstract availableKeywords
Funding Information
- Department of Anesthesia, University Hospital Basel, Switzerland
- Swiss National Science Foundation (32-118092)
This publication has 43 references indexed in Scilit:
- Genotype-phenotype correlations in recessive RYR1-related myopathiesOrphanet Journal of Rare Diseases, 2013
- Characterizing and measuring bias in sequence dataGenome Biology, 2013
- Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) geneNeuromuscular Disorders, 2010
- The role of CACNA1Sin predisposition to malignant hyperthermiaBMC Medical Genetics, 2009
- Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysisNeurology, 2009
- Increasing the number of diagnostic mutations in malignant hyperthermiaHuman Mutation, 2009
- A Double Mutation of the Ryanodine Receptor Type 1 Gene in a Malignant Hyperthermia Family with Multiminicore MyopathyJournal of Clinical Neurology, 2008
- High Throughput Genetic Analysis of Congenital Myasthenic Syndromes Using Resequencing MicroarraysPLOS ONE, 2007
- Explaining differences in saturation levels for Affymetrix GeneChip® arraysNucleic Acids Research, 2007
- Mutations inRYR1in malignant hyperthermia and central core diseaseHuman Mutation, 2006